scispace - formally typeset
O

Olivier Dormond

Researcher at University of Lausanne

Publications -  77
Citations -  3661

Olivier Dormond is an academic researcher from University of Lausanne. The author has contributed to research in topics: PI3K/AKT/mTOR pathway & Angiogenesis. The author has an hindex of 30, co-authored 71 publications receiving 3094 citations. Previous affiliations of Olivier Dormond include Boston Children's Hospital & Harvard University.

Papers
More filters
Journal ArticleDOI

NSAIDs inhibit alpha V beta 3 integrin-mediated and Cdc42/Rac-dependent endothelial-cell spreading, migration and angiogenesis.

TL;DR: Results establish a novel functional link between COX-2, integrin αVβ3 and Cdc42-/Rac-dependent endothelial-cell migration and provide a rationale to the understanding of the anti-angiogenic activity of NSAIDs.
Journal ArticleDOI

PI3K and AKT: Unfaithful Partners in Cancer

TL;DR: The complex relationship between PI3K and AKT in cancer is highlighted and the consequences for cancer therapy are discussed, revealing another level of complexity in this pathway.
Journal ArticleDOI

Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12.

TL;DR: It is important to consider the interactions and crosstalk between these three chemokine receptors and their ligand mediated signaling cascades for the development of effective anti-cancer therapies.
Journal ArticleDOI

Prostaglandin E2 Promotes Integrin αVβ3-dependent Endothelial Cell Adhesion, Rac-activation, and Spreading through cAMP/PKA-dependent Signaling

TL;DR: It is demonstrated that PGE2 accelerates αVβ3-mediated endothelial cell adhesion through cAMP-dependent PKA activation and induces αV β3-dependent spreading via camp- and PKA-dependent Rac activation and may contribute to the further understanding of the regulation of vascular integrins αvβ3 by COX-2/PGE2 during tumor angiogenesis and inflammation.